Ionis Pharma (IONS) Reports Q2 Loss of $0.09/Share

Ionis Pharma (NASDAQ: IONS) reported Q2 EPS of ($0.09), versus ($0.47) reported last year. Revenue for the quarter came in at $104.2 million, versus $38.5 million reported last year.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Ionis Pharmaceuticals (IONS) PT Raised to $130 at H.C. Wainwright
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook
• Darden Restaurants (DRI) Tops Q4 EPS by 3c, Misses on Revenue; Offers FY27 Guidance